ArticleCancers2022

Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer.

Vasiliki Vafeiadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.